Site US00165 — Wilmington, North Carolina

Site US00165 is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US00165 has participated in 1 clinical trials.

Therapeutic areas: Overactive Bladder (OAB).

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

• New Hanover Regional Hospital
• Betty Cameron Women & Children's Hospital
• PMG Research of Wilmington
• Research Site
• GSK Investigational Site
• Trial Management Associates
• New Hanover Regional Medical Center
• Accellacare
• Novant Health New Hanover Regional Medical Center
• Accellacare-Wilmington
• Novo Nordisk Investigational Site
• Wilmington Dermatology Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00165?

Site US00165 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00165 conducted?

Site US00165 has 1 clinical trials on record. Their work covers Overactive Bladder (OAB).

Is Site US00165 accredited by Crixeo Clinical Trials?

Site US00165 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00165?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.